GO:0015878 biotin transport: Genes and Research

GO:0015878 biotin transport is the biological process describing the directed movement of biotin into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Biotin, also known as vitamin B7 or vitamin H, is cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid; its (+) enantiomer is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions. Because biotin is water-soluble and cannot freely diffuse across lipid bilayers at physiologically relevant rates, dedicated transport systems are required for its uptake and distribution. Researchers study biotin transport to understand micronutrient homeostasis, intestinal absorption, tissue-specific delivery, and the metabolic consequences of biotin deficiency. In the human intestine, biotin transport is carrier-mediated, pH-dependent, and maximal in the proximal small intestine, indicating a specialized apical uptake mechanism. In human liver, basolateral membrane vesicles transport biotin by a carrier-mediated, Na+ gradient-dependent process, suggesting distinct membrane domains use different driving forces. Human keratinocytes and the Caco-2 intestinal epithelial cell line both actively transport biotin, providing tractable cellular models for mechanistic and pharmacological studies. Biotin transport is also relevant to microbial physiology and biotechnology. Rhizobia possess biotin biosynthesis, transport, and utilization pathways that support symbiotic nitrogen fixation. A biotin-deficient Escherichia coli strain transports biotin via a specific uptake system, enabling genetic dissection of transporter function. Ontogenetic studies in the rat show that intestinal biotin transport develops after birth, highlighting developmental regulation of this process. Together, these findings establish GO:0015878 as a conserved, multi-model process with direct implications for nutrition, metabolism, and cell engineering.

GO:0015878 biotin transport is defined as the directed movement of biotin into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Biotin is cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid; the (+) enantiomer is very widely distributed in cells and serves as a carrier in a number of enzymatic beta-carboxylation reactions. Synonyms include vitamin B7 transport and vitamin H transport.

Biotin transport is essential because biotin serves as a covalently bound carrier in enzymatic beta-carboxylation reactions, and cells must acquire this water-soluble vitamin through dedicated transport systems. In humans, carrier-mediated intestinal absorption determines systemic biotin availability, while Na+ gradient-dependent liver basolateral transport governs hepatic handling of the vitamin. Defects or dysregulation of biotin transport can therefore influence metabolic flux, nutrient status, and tissue-specific biotin delivery. Because biotin transport is conserved and experimentally tractable in bacteria, animal models, and human cell lines, it is a valuable system for studying membrane transport mechanisms, nutritional regulation, and host-microbe interactions.

The following genes and proteins have been experimentally implicated in biotin transport or related biotin handling across human, animal, and microbial systems.

Biotin transport is regulated at multiple levels. In the human intestine, transport is pH-dependent and maximal in the proximal small intestine, indicating that local pH and regional specialization regulate uptake. In human liver basolateral membranes, transport is Na+ gradient-dependent, linking biotin movement to sodium homeostasis. Developmental regulation is evident in the rat, where intestinal biotin transport changes during ontogenesis. In rhizobia, biotin biosynthesis, transport, and utilization are coordinated, suggesting pathway-level regulation. In E. coli, biotin deficiency induces a specific transport system, indicating substrate-dependent regulation.

Because biotin serves as a carrier in enzymatic beta-carboxylation reactions, impaired biotin transport can reduce intracellular biotin availability and compromise carboxylase-dependent metabolism. Intestinal transport defects would be expected to impair absorption, particularly given that maximum transport occurs in the proximal small intestine. Liver basolateral transport defects could alter hepatic biotin handling and systemic distribution.

Human keratinocytes transport biotin, linking biotin transport to skin cell biology. Intestinal epithelial Caco-2 cells also transport biotin, providing a model for epithelial transport dysfunction. These findings suggest that epithelial transport systems are relevant to dermatological and gastrointestinal conditions associated with biotin status.

Rhizobia require biotin biosynthesis, transport, and utilization for symbiotic function, indicating that biotin transport influences host-microbe interactions. The biotin-deficient E. coli strain provides a model for studying bacterial biotin transport and its role in microbial growth. These systems are relevant to understanding how microbiota acquire and compete for biotin.

Radiolabeled or fluorescent biotin uptake assays in Caco-2 and keratinocyte models measure carrier-mediated transport and its pH dependence. These assays can be combined with knockout or overexpression to assign function to candidate genes.

Human liver basolateral membrane vesicles allow direct measurement of Na+ gradient-dependent biotin transport, isolating the basolateral step from cellular metabolism. Similar vesicle systems can be used to test driving forces and inhibitor sensitivity.

Rat intestinal transport studies across ages reveal ontogenetic regulation of biotin uptake. These models are useful for linking transport capacity to physiological stages.

The biotin-deficient E. coli strain enables genetic screens and transport assays for bacterial biotin uptake. Rhizobia systems allow study of biotin transport in symbiotic contexts.

Researchers studying biotin transport-related genes often need to determine whether a candidate gene is causally involved in biotin uptake, whether a specific variant alters transport kinetics, and how transport capacity changes under physiological or pathological conditions. Addressing these questions requires precise, reproducible cell models that isolate the transport step from downstream metabolism.

GO:0015878 biotin transport is a conserved biological process that governs the directed movement of biotin into, out of, and within cells. Experimental evidence from human intestine, liver, keratinocytes, Caco-2 cells, rat development, rhizobia, and E. coli shows that biotin transport is carrier-mediated, pH- and Na+ gradient-dependent, and developmentally regulated. Because biotin is a carrier in enzymatic beta-carboxylation reactions, understanding its transport is central to nutrition, metabolism, and cell engineering. CRISPR-based knockout, point-mutation, knock-in, and overexpression models in relevant cell types provide precise tools to dissect biotin transport mechanisms and candidate genes. Combined with transport assays, membrane vesicle studies, and microbial genetics, these approaches support rigorous, publication-ready research on GO:0015878.